[144] Horace Mann Educators Corporation SEC Filing

Rhea-AI Filing Summary

Horace Mann Educators Corporation (HMN) Form 144 shows proposed and recent insider sales of common stock by Marita Zuraitis. The notice reports a proposed sale of 5,000 shares to be executed approximately on 09/02/2025 through Fidelity Brokerage Services (NYSE), with an aggregate market value of $228,800.00 based on the filing. The filer discloses acquisition details: 5,000 shares were acquired in 2023 via restricted stock vesting (264 on 01/01/2023, 2,195 on 03/04/2023, and 2,541 on 03/09/2023) as compensation. The filing also lists prior sales by the same person in the past three months: 5,000 shares on 06/02/2025 for $216,200.00, 5,000 on 07/01/2025 for $214,350.00, and 5,000 on 08/01/2025 for $211,400.00. The signer certifies no undisclosed material adverse information.

Positive

• Regulatory compliance: The filer submitted a Form 144 disclosing proposed and recent insider sales, meeting Rule 144 disclosure requirements.
• Clear provenance of shares: Acquisition table shows shares were received via restricted stock vesting in 2023 as compensation.

Negative

• Insider sales activity: The filing documents repeated sales (5,000 shares in June, July, August 2025 and a proposed 5,000 on September 2, 2025), which increases share supply from an affiliate.
• No 10b5-1 plan date provided: The filing does not state a written trading plan adoption date within this document, so sales are reported as proposed under Rule 144 rather than under an explicitly dated prearranged plan.

Insights

Securities Analyst

TL;DR: Routine insider sales disclosed; no additional operational or financial data provided to assess broader impact.

The Form 144 is a standard regulatory notice required when an affiliate proposes to sell restricted or control shares under Rule 144. The filing documents that 5,000 shares are proposed for sale on 09/02/2025 through a NYSE broker and confirms the shares originated from 2023 restricted stock vesting. The filing itself contains no operational metrics, revenue, or forward guidance; therefore its material informational content is limited to insider liquidity actions. For investors, this provides transparency about share disposition timing and amounts but does not, by itself, quantify company performance or change valuation drivers.

Corporate Governance Expert

TL;DR: Disclosure aligns with compliance expectations; repeated monthly sales are documented but no governance concerns are stated.

The document indicates the insider has sold shares in June, July, and August 2025 and plans an additional sale in September 2025. All acquisitions listed are via restricted stock vesting in early 2023 and were paid as compensation. The filer signs the required certification regarding material nonpublic information. There is no disclosure in this filing of any policy change, related-party transaction, or 10b5-1 plan adoption date; absence of a stated plan date means the sale appears to be reported as proposed sales under Rule 144 rather than as sales under an explicit pre-established trading plan in this document.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	5000	228800.00	40695729	09/02/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/01/2023	Restricted Stock Vesting	Issuer			264	01/01/2023	Compensation
Common	03/04/2023	Restricted Stock Vesting	Issuer			2195	03/04/2023	Compensation
Common	03/09/2023	Restricted Stock Vesting	Issuer			2541	03/09/2023	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Marita Zuraitis 1 Horace Mann Plaza Springfield IL 62715-0001	Common	06/02/2025	5000	216200.00
Marita Zuraitis 1 Horace Mann Plaza Springfield IL 62715-0001	Common	07/01/2025	5000	214350.00
Marita Zuraitis 1 Horace Mann Plaza Springfield IL 62715-0001	Common	08/01/2025	5000	211400.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Horace Mann's (HMN) Form 144 disclose about proposed insider sales?

The Form 144 discloses a proposed sale of 5,000 common shares on approximately 09/02/2025 through Fidelity (NYSE) with an aggregate market value of $228,800.00.

Who is the seller named in the HMN Form 144 and how many shares were sold recently?

The seller is Marita Zuraitis. The filing reports past sales of 5,000 shares on 06/02/2025, 5,000 on 07/01/2025, and 5,000 on 08/01/2025.

How were the shares being sold by the insider acquired according to the filing?

The shares were acquired through restricted stock vesting in 2023 (264 shares on 01/01/2023; 2,195 on 03/04/2023; 2,541 on 03/09/2023) and are labeled as compensation.

Does the Form 144 indicate whether a 10b5-1 trading plan was used for these sales?

This Form 144 does not provide a date of plan adoption or instruction that would indicate reliance on a 10b5-1 trading plan within the filing.

What certification does the signer make on the Form 144?

The signer represents they do not know any material adverse information about the issuer that has not been publicly disclosed.